For the quarter ending 2026-03-31, PMI made $1,150,000 in revenue. -$7,616,000 in net income. Net profit margin of -662.26%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 1,150,000 | -37,000* | 1,187,000 | 2,131,000 |
| Product | 437,000 | -214,500* | 880,000 | - |
| Rentals | 438,000 | -4,000* | 437,000 | 707,000 |
| Cost of revenues | 875,000 | -218,500* | 1,317,000 | 2,258,000 |
| Gross profit (gain) | 275,000 | 181,500* | -130,000 | -127,000 |
| Research and development | 1,895,000 | 508,000* | 951,000 | 743,000 |
| Selling, general and administrative | 2,891,000 | 2,418,500* | 2,406,000 | 2,651,000 |
| Total operating expenses | 4,786,000 | 2,926,500* | 3,357,000 | 3,394,000 |
| Operating loss | -4,511,000 | -2,745,000* | -3,487,000 | -3,521,000 |
| Interest expense | -5,000 | 1,819,000* | -2,404,000 | - |
| Derivative gain | 0 | 25,750* | -4,535,000 | - |
| Change in fair value of senior secured note and warrant liability | 2,998,000 | 254,250* | - | - |
| Financing charges | - | 573,500* | - | - |
| Loss on settlement of debt | -6,098,000 | - | - | - |
| Total other income (expenses), net | -3,105,000 | 1,525,500* | -6,939,000 | - |
| Loss before income taxes | -7,616,000 | -1,219,500* | -10,426,000 | -6,724,000 |
| Provision for income taxes | 0 | 35,000* | 0 | 0 |
| Net loss | - | - | - | -6,724,000 |
| Net loss | -7,616,000 | -1,254,500* | -10,426,000 | -6,724,000 |
| Foreign currency translation adjustments, net of tax | - | - | - | -15,000 |
| Undeclared series a-1 preferred dividends | 0 | 0* | 0 | - |
| Comprehensive loss | - | - | - | -6,739,000 |
| Net loss attributable to common stockholders | -7,616,000 | -1,254,500 | -10,426,000 | -7,520,000 |
| Basic EPS | -0.1 | -0.07 | -0.19 | - |
| Basic Average Shares | 74,437,715 | 18,014,028 | 54,452,140 | - |
Picard Medical, Inc. (PMI)
Picard Medical, Inc. (PMI)